W. Ledger

Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Diseases Society of America and the Food and Drug Administration.

S. Gorbach, A. B. Kaiser, R. Nichols, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomy.

J. Orr, B. Sevin, A. Berkeley, 1988, American journal of surgery.

Current problems in antibiotic treatment in obstetrics and gynecology.

W. Ledger, 1985, Reviews of infectious diseases.

Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients.

N. Noyes, A. Berkeley, W. Ledger, 1998, Infectious diseases in obstetrics and gynecology.

Cefotaxime for cesarean section prophylaxis in labor. Intravenous administration vs. lavage.

A. Berkeley, W. Ledger, K. Freedman, 1990, The Journal of reproductive medicine.

Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease.

N. Osborne, M. Martens, J. Thomason, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Imipenem/cilastatin in the treatment of obstetric and gynecologic infections.

A. Berkeley, W. Ledger, K. Freedman, 1985, The American journal of medicine.

Controlled, comparative study of moxalactam and cefazolin for prophylaxis of abdominal hysterectomy

A. Berkeley, W. Ledger, K. Freedman, 1985, Surgery, gynecology & obstetrics.

Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.

A. Berkeley, W. Ledger, K. Freedman, 1986, Surgery, gynecology & obstetrics.